Cardiology
Commentary
Universal testing for Lp(a): What are we waiting for?
A resurgent interest in molecular pathophysiology this past decade has clarified Lp(a)’s unique contribution to atherothrombotic disease and...
From the Journals
CV deaths jumped in 2020, reflecting pandemic toll
The American Heart Association 2020 Statistical Update offers lessons for addressing structural issues that drive health disparities.
Livin' on the MDedge
The long-range thrombolysis forecast calls for tiny ultrasonic tornadoes
Plus: The overestimated intelligence of age and the shoes that save relationships.
Latest News
Autism linked to problems with cardiovascular health
Children with autism were almost twice as likely as their peers to develop diabetes and high blood pressure.
From the Journals
Long QT syndrome overdiagnosis persists
Five ‘diagnostic miscues’ underlie overdiagnosis and misdiagnosis of long QT syndrome, which can profoundly affect patients’ quality of life.
Latest News
Elevated PCSK9 levels associated with psoriasis suggest new treatment target
A large population analysis implicates PCSK9 as a target in prevention of psoriasis.
From the Journals
Angioedema risk jumps when switching HF meds
The risk for angioedema rises when switching from an ARB or ACE inhibitor to ARNI, observational data suggest.
From the Journals
Noninvasive liver test may help select asymptomatic candidates for heart failure tests
Heart failure and liver stiffness often coexist due to cardio-hepatic interactions.
Clinical Inquiries
Does regular walking improve lipid levels in adults?
EVIDENCE-BASED ANSWER: Minimally. Regular moderate- intensity walking for a period of 4 or more weeks minimally decreased total cholesterol (TC)...
Commentary
Novel resuscitation for patients with nonshockable rhythms in cardiac arrest
CPR has been life saving for 60 years the way we’ve performed it, but probably only in a very small percentage of cases.
From the Journals
More type 2 diabetes deaths from cancer than heart disease
In people with type 2 diabetes, cancer screening should get at least as much attention as CVD prevention.